Curium Pharma data breach
Curium Pharma has reported a data breach impacting individuals to authorities in New Hampshire, with the official filing date of June 24, 2025. This incident is currently under investigation, and affected individuals may be wondering about the security of their personal information and potential next steps.
Docket sheet
- Company
- Curium Pharma
- Venue
- NH Attorney General
- Filed
- June 24, 2025
- People affected
- Not stated
- Status
- Investigation Open
Where this breach stands
- 1
Breach occurred
The filing does not state when the incident happened.
- 2
Reported to the NH Attorney GeneralJune 24, 2025
The company filed a breach notification with the state regulator.
- 3
Attorney reviewCurrent stage
Current status: Investigation Open. Our office is reviewing whether affected people may have claims.
- 4
Your case review
Got a letter about this breach? Submit it for a free, confidential review.
Clerk's notes
Curium Pharma, a company operating in New Hampshire, officially reported a data breach to regulators on June 24, 2025. The specific details regarding how the breach occurred and its full scope are still being investigated at this time. This filing marks the beginning of the formal review process for the incident, with authorities actively examining the circumstances.
For individuals who have received a notification letter from Curium Pharma, this means that their personal information may have been accessed without authorization. While the precise types of data involved have not been publicly specified, any compromise of personal data can carry risks. Understanding the situation is the first step toward protecting yourself.
To safeguard against potential misuse of your data, it is advisable to remain vigilant. Carefully review any account statements for unusual activity and be cautious of unsolicited communications, especially those asking for personal details. Promptly report anything suspicious to the relevant financial institutions or service providers.
If you have received a notification regarding the Curium Pharma data breach, you may be eligible to seek further recourse. A free, no-obligation case review can help clarify your options and determine if your specific circumstances warrant further action. This process can provide valuable insight without establishing an attorney-client relationship.
If a notification letter about this breach reached you, see every NH data breach on file or browse all cases.
Other NH docket entries
- Janome America, Inc.New Hampshire AGJuly 31, 2026Investigation Open
- Sullivan Environmental ServicesNew Hampshire AGJuly 31, 2026Investigation Open
- City of New Britain, Inc.New Hampshire AGJuly 30, 2026Investigation Open
- New Hampshire Housing Yardi’s RentCafeNew Hampshire AGJuly 30, 2026Investigation Open
- Pocket FMNew Hampshire AGJuly 30, 2026Investigation Open
- Ameriprise FinancialNew Hampshire AGJuly 29, 2026Investigation Open
- Joyal Financial Management GroupNew Hampshire AGJuly 29, 2026Investigation Open
- Quantum HealthNew Hampshire AGJuly 29, 2026Investigation Open
Attorney advertising. A docket entry reflects a public regulator filing and our review status; it does not mean a lawsuit has been filed. Submitting a review request does not create an attorney-client relationship.